DalsnaFinance › IPOs › Alto Neuroscience › IPO
Alto Neuroscience, Inc. completed its initial public offering on NYSE on February 2, 2024, pricing at $16.00 a share.
| Ticker | ANRO |
|---|---|
| Exchange | NYSE |
| Status | Completed |
| Listing date | February 2, 2024 |
| Offering price | $16.00 |
| Shares offered | 8,040,000 |
| Total raised | $129M |
Alto Neuroscience, Inc. sold 8,040,000 shares at $16.00 each on NYSE. Multiplied out, that is $128.6 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $129 million total recorded for the deal.
Alto Neuroscience, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Alto Neuroscience, Inc.. This page is general information, not investment advice.